Are you living with Type 1 Diabetes?

This study is investigating a once-weekly long-acting insulin (Insulin Icodec) compared to daily Insulin Glargine, both used in combination with insulin aspart, in adults living with type 1 diabetes with an HbA1c between 7–10%.

You may be eligible to participate in this clinical study if you meet the following criteria:

• 18 years of age

• Using multiple daily injections for more than 6 months

• Diagnosed with type 1 diabetes for more than 1 year

• Have an A1c between 7.0-10.0%

There is no cost to participate and once enrolled in the study, participants will be compensated for time and travel.